Jessica Reed serves as Vice President of Development for Diapin Therapeutics, LLC. Dr. Reed is an experienced Pharmaceutical Director, having lead multiple successful projects including 7 INDs and 7 NDA/sNDA submissions. Key contributor to teams that have delivered five pre-clinical candidates one of which advanced to market for the treatment of cancer (dacomitinib) Vizimpro, and one that advanced to phase I, for diabetes. Advanced ten discovery projects in oncology, CNS, and metabolic disease groups, providing leadership and scientific oversight to teams of cross functional scientists. Jessica is highly engaged, with excellent project management, communication, problem solving, organizational and analytical skills. She has over 20 years of experience in the pharmaceutical industry with a proven record of accomplishment in discovery, nonclinical and clinical research projects.